1
|
DeAngelis LM: Brain tumors. N Engl J Med.
344:114–123. 2001. View Article : Google Scholar : PubMed/NCBI
|
2
|
Stupp R, Mason WP, van den Bent MJ, et al:
European Organisation for Research and Treatment of Cancer Brain
Tumor and Radiotherapy Groups; National Cancer Institute of Canada
Clinical Trials Group: Radiotherapy plus concomitant and adjuvant
temozolomide for glioblastoma. N Engl J Med. 352:987–996. 2005.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Ravizza R, Cereda E, Monti E and Gariboldi
MB: The piperidine nitroxide Tempol potentiates the cytotoxic
effects of temozolomide in human glioblastoma cells. Int J Oncol.
25:1817–1822. 2004.PubMed/NCBI
|
4
|
Bruyere C, Mijatovic T, Lonez C, et al:
Temozolomide-induced modification of the CXC chemokine network in
experimental gliomas. Int J Oncol. 38:1453–1464. 2011.PubMed/NCBI
|
5
|
Ashizawa T, Akiyama Y, Miyata H, et al:
Effect of the STAT3 inhibitor STX-0119 on the proliferation of a
temozolomide-resistant glioblastoma cell line. Int J Oncol.
45:411–418. 2014.PubMed/NCBI
|
6
|
Shi L, Zhang S, Feng K, et al:
MicroRNA-125b-2 confers human glioblastoma stem cells resistance to
temozolomide through the mitochondrial pathway of apoptosis. Int J
Oncol. 40:119–129. 2012.PubMed/NCBI
|
7
|
Fouse SD, Nakamura JL, James CD, Chang S
and Costello JF: Response of primary glioblastoma cells to therapy
is patient specific and independent of cancer stem cell phenotype.
Neuro Oncol. 16:361–371. 2014. View Article : Google Scholar : PubMed/NCBI
|
8
|
Estrada-Bernal A, Palanichamy K, Ray
Chaudhury A and Van Brocklyn JR: Induction of brain tumor stem cell
apoptosis by FTY720: a potential therapeutic agent for
glioblastoma. Neuro Oncol. 14:405–415. 2012. View Article : Google Scholar : PubMed/NCBI
|
9
|
Rich JN: Cancer stem cells in radiation
resistance. Cancer Res. 67:8980–8984. 2007. View Article : Google Scholar : PubMed/NCBI
|
10
|
Bao S, Wu Q, McLendon RE, et al: Glioma
stem cells promote radioresistance by preferential activation of
the DNA damage response. Nature. 444:756–760. 2006. View Article : Google Scholar : PubMed/NCBI
|
11
|
Wu J, Lai G, Wan F, Xiao Z, Zeng L, et al:
Knockdown of checkpoint kinase 1 is associated with the increased
radiosensitivity of glioblastoma stem-like cells. Tohoku J Exp Med.
226:267–274. 2012. View Article : Google Scholar : PubMed/NCBI
|
12
|
Soeda A, Park M, Lee D, et al: Hypoxia
promotes expansion of the CD133-positive glioma stem cells through
activation of HIF-1alpha. Oncogene. 28:3949–3959. 2009. View Article : Google Scholar : PubMed/NCBI
|
13
|
Christensen K, Aaberg-Jessen C, Andersen
C, Goplen D, Bjerkvig R and Kristensen BW: Immunohistochemical
expression of stem cell, endothelial cell and chemosensitivity
markers in primary glioma spheroids cultured in serum-containing
and serum-free medium. Neurosurgery. 66:933–947. 2010. View Article : Google Scholar : PubMed/NCBI
|
14
|
Zhang M, Song T, Yang L, et al: Nestin and
CD133: Valuable stem cell-specific markers for determining clinical
outcome of glioma patients. J Exp Clin Cancer Res. 27(85)2008.
|
15
|
Li Z, Musich PR, Cartwright BM, Wang H and
Zou Y: UV-induced nuclear import of XPA is mediated by
importin-alpha4 in an ATR-dependent manner. PloS One. 8:e682972013.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Li Z, Musich PR and Zou Y: Differential
DNA damage responses in p53 proficient and deficient cells:
Cisplatin-induced nuclear import of XPA is independent of ATR
checkpoint in p53-deficient lung cancer cells. Int J Biochem Mol
Biol. 2:138–145. 2011.PubMed/NCBI
|
17
|
Li Z, Musich PR, Serrano MA, Dong Z and
Zou Y: XPA-mediated regulation of global nucleotide excision repair
by ATR is p53-dependent and occurs primarily in S-phase. PloS One.
6:e283262011. View Article : Google Scholar : PubMed/NCBI
|
18
|
Gatei M, Jakob B, Chen P, et al: ATM
protein-dependent phosphorylation of Rad50 protein regulates DNA
repair and cell cycle control. J Biol Chem. 286:31542–31556. 2011.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Machida K, McNamara G, Cheng KT, et al:
Hepatitis C virus inhibits DNA damage repair through reactive
oxygen and nitrogen species and by interfering with the
ATM-NBS1/Mre11/Rad50 DNA repair pathway in monocytes and
hepatocytes. J Immunol. 185:6985–6998. 2010. View Article : Google Scholar : PubMed/NCBI
|
20
|
Kuroda S, Fujiwara T, Shirakawa Y, et al:
Telomerase-dependent oncolytic adenovirus sensitizes human cancer
cells to ionizing radiation via inhibition of DNA repair machinery.
Cancer Res. 70:9339–9348. 2010. View Article : Google Scholar : PubMed/NCBI
|
21
|
Grishin AV, Azhipa O, Semenov I and Corey
SJ: Interaction between growth arrest-DNA damage protein 34 and Src
kinase Lyn negatively regulates genotoxic apoptosis. Proc Natl Acad
Sci USA. 98:10172–10177. 2001. View Article : Google Scholar : PubMed/NCBI
|
22
|
Hollander MC, Zhan Q, Bae I and Fornace AJ
Jr: Mammalian GADD34, an apoptosis- and DNA damage-inducible gene.
J Biol Chem. 272:13731–13737. 1997. View Article : Google Scholar : PubMed/NCBI
|
23
|
Hollander MC, Sheikh MS, Yu K, et al:
Activation of Gadd34 by diverse apoptotic signals and suppression
of its growth inhibitory effects by apoptotic inhibitors. Int J
Cancer. 96:22–31. 2001. View Article : Google Scholar : PubMed/NCBI
|
24
|
Adler HT, Chinery R, Wu DY, et al:
Leukemic HRX fusion proteins inhibit GADD34-induced apoptosis and
associate with the GADD34 and hSNF5/INI1 proteins. Mol Cell Biol.
19:7050–7060. 1999.PubMed/NCBI
|